¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Çѱ¹ÁöÁú¤ýµ¿¸Æ°æÈ­ÇÐȸ The 10th International Congress on Lipid & Atherosclerosis (ICoLA 2021) 1ÀÏÂ÷ : 2021-09-10

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
Çѱ¹ÁöÁú¤ýµ¿¸Æ°æÈ­ÇÐȸ The 10th International Congress on Lipid & Atherosclerosis (ICoLA 2021) 1ÀÏÂ÷ : 2021-09-10
±³À°ÀÏÀÚ : 2021-09-10
±³À°Àå¼Ò : ÄÜ·¡µåÈ£ÅÚ ¼­¿ï(¿Â¶óÀÎ º´Çà)  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ&¿ÀÇÁ¶óÀÎ º´Çà) The 10th International Congress on Lipid & Atherosclerosis (ICoLA 2021) 1ÀÏÂ÷
ÁÖÃÖ±â°ü : Çѱ¹ÁöÁú¤ýµ¿¸Æ°æÈ­ÇÐȸ
´ã´çÀÚ : ICoLA2021 »ç¹«±¹
¿¬¶ôó : 02-2135-3618  
À̸ÞÀÏ : secretariat@icola.org      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 700¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 27 ½Ã°£ 35ºÐ  
¼¼ºÎ¼ö°­·á : 100,000¿ø      
ºñ°í Àü¹®ÀÇ, ±³¼ö : 100,000¿ø / ÀüÀÓÀÇ, Àü°øÀÇ, ±ºÀÇ°ü, ¿¬±¸¿ø, Çлý µî : 4¸¸¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09-10 Room 1 08:00~08:20 For today for tomorrow, cardiorenal benefit of dapagliflozin  Jae Hyuk Lee(Myongji Hospital, Korea) 
Åä·Ð 09-10 Room 1 08:20~08:30 Discussion  () 
±³À°½Ã°£ 09-10 Room 2 08:00~08:20 Can my elderly AF patients benefit in anticoagulation? : broad data of Eliquis can tell  Seung Yong Shin(Chung-Ang University, Korea) 
Åä·Ð 09-10 Room 2 08:20~08:30 Discussion  () 
±³À°½Ã°£ 09-10 Room 3 08:00~08:20 A novel strategy for the lipid management of recent ACS patients  Jin Joo Park(Seoul National University, Korea) 
±³À°½Ã°£ 09-10 Room 3 08:20~08:30 Discussion  () 
±³À°½Ã°£ 09-10 Room 1+2+3 09:00~09:30 What's new in epidemiology of ASCVD & risk factors  Raul Santos(University of Sao Paulo, Brazil) 
È޽Ġ09-10  09:30~09:40 Break  () 
±³À°½Ã°£ 09-10 Room 1 09:40~10:03 NAFLD, NASH & cardiovascular disease  Masahiro Koseki(Osaka University, Japan) 
±³À°½Ã°£ 09-10 Room 1 10:03~10:26 Leukocytes, inflammation, and atherosclerosis  Marit Westerterp(University of Groningen, Netherlands) 
±³À°½Ã°£ 09-10 Room 1 10:26~10:49 Heterogeneity of NAFLD the perspective of atherosclerosis  Bo Kyung Koo(Seoul National University, Korea) 
Åä·Ð 09-10 Room 1 10:49~11:15 Discussion  () 
±³À°½Ã°£ 09-10 Room 2 09:40~10:03 Integration of new imaging or biomarkers to risk calculators  Chang-Yeon Kim(Daegu Catholic University, Korea) 
±³À°½Ã°£ 09-10 Room 2 10:03~10:26 Understanding cardiovascular risk: using risk scores and other risk-based testing in the contemporary era  Ian Neeland(University Hospitals Cleveland Medical Center, USA) 
±³À°½Ã°£ 09-10 Room 2 10:26~10:49 Risk model for CV risk assessment in Korean population  Seung-Hwan Lee(The Catholic University of Korea, Korea) 
Åä·Ð 09-10 Room 2 10:49~11:15 Discussion  () 
±³À°½Ã°£ 09-10 Room 3 09:40~10:03 Mapping genetic associations to novel therapeutics for cardiometabolic disease  Pradeep Natarajan(Harvard Medical School, USA) 
±³À°½Ã°£ 09-10 Room 3 10:03~10:26 Clinical implication of recent epigenetic studies on CAD & dyslipidemia  Sung Ho Park(UNIST, Korea) 
±³À°½Ã°£ 09-10 Room 3 10:26~10:49 How can we derive biological relevance genetic studies on atherosclerosis?  Mete Civelek(University of Virginia, USA) 
Åä·Ð 09-10 Room 3 10:49~11:15 Discussion  () 
±³À°½Ã°£ 09-10 Room 4 09:40~10:03 Myeloid cell heterogeneity in hyperlipidemic cardiovascular diseases  Jae Hoon Choi(Hanyang University, Korea) 
±³À°½Ã°£ 09-10 Room 4 10:03~10:26 Role of immune cells in the regression of atherosclerosis  Edward A. Fisher(NYU Grossman School of Medicine, USA) 
±³À°½Ã°£ 09-10 Room 4 10:26~10:49 Role of LYVE-1+ macrophage in arterial diseases  Veronique Angeli(National University of Singapore, Singapore) 
Åä·Ð 09-10 Room 4 10:49~11:15 Discussion  () 
±³À°½Ã°£ 09-10 Room 5 09:40~10:03 Cellular plasticity in atherosclerosis  Judith Sluimer(Maastricht University, Netherlands) 
±³À°½Ã°£ 09-10 Room 5 10:03~10:26 New mechanism of vascular calcification  Byeong Hwa Jeon(Chungnam National University, Korea) 
±³À°½Ã°£ 09-10 Room 5 10:26~10:49 Phenotypic changes of VSMC in atherosclerosis  Chang Seon Myung(Chungnam National University, Korea) 
Åä·Ð 09-10 Room 5 10:49~11:15 Discussion  () 
È޽Ġ09-10  11:15~11:25 Break  () 
±âŸ 09-10  11:25~11:35 Opening Address  () 
±³À°½Ã°£ 09-10 Room 1+2+3 11:35~12:05 Single cell RNA and antibody sequencing in women and men with cardiovascular disease  Klaus Ley(La Jolla Institute for Immunology, USA) 
±³À°½Ã°£ 09-10 Room 1 12:05~12:25 Insight for T2DM and/or metabolism syndrome with complication to manage dyslipidemia  Seung-Hwan Lee(The Catholic University of Korea, Korea) 
Åä·Ð 09-10 Room 1 12:25~12:35 Discussion  () 
±³À°½Ã°£ 09-10 Room 2 12:05~12:25 Familial hypercholesterolemia: diagnosis and management  Chan Joo Lee(Yonsei University, Korea) 
Åä·Ð 09-10 Room 2 12:25~12:35 Discussion  () 
±³À°½Ã°£ 09-10 Room 3 12:05~12:25 What are the optimal options of dyslipidemia management for your patients? based on treatment continuum  Hyun Jae Kang(Seoul National University, Korea) 
Åä·Ð 09-10 Room 3 12:25~12:35 Discussion  () 
Åä·Ð 09-10 Room 4 12:25~12:35 Discussion  () 
±³À°½Ã°£ 09-10 Room 4 12:05~12:25 Lipid management: to the perfection and state of art  Hyo-In Choi(Sungkyunkwan University, Korea) 
±³À°½Ã°£ 09-10 Room 1 13:05~13:12 Hippo/Mst1 is essential for adipogenic aging  Je-Hyun Yoon(Medical University of South Carolina, USA) 
±³À°½Ã°£ 09-10 Room 1 13:12~13:19 LncRNA H1 sponges miR223 to enhance proinflammatory changes of vascular smooth muscle cells  Soo-jin Ann(Yonsei University, Korea) 
±³À°½Ã°£ 09-10 Room 1 13:19~13:26 Development of hemodynamic biomarker for carotid atherosclerosis based on the results of in-vitro phantom study using 4D-flow MRI  Don-Gwan An(Hanyang University, Korea) 
±³À°½Ã°£ 09-10 Room 1 13:26~13:33 Effect of elevated uric acid by fructose overload on NASH and atherosclerosis  Moe Fujii(Okayama University, Japan) 
±³À°½Ã°£ 09-10 Room 1 13:33~13:40 Plasma oxidized LDL induces procoagulant profiles in subjects with borderline hypercholesterolemia by increasing lysophosphatidylcholine levels and Lp-PLA2 activity?  Ximei Huang(Hannam University, Korea) 
Åä·Ð 09-10 Room 1 13:40~14:05 Q&A  () 
±³À°½Ã°£ 09-10 Room 3 13:05~13:12 Exploring the genetic associations between the use of statins and Alzheimer¡¯s disease  Jibeom Lee(Gwangju Institue of Science and Technology, Korea) 
±³À°½Ã°£ 09-10 Room 3 13:12~13:19 Triglyceride?glucose index is a useful marker for predicting atherosclerotic cardiovascular disease in young adults: a nationwide population-based cohort study  Yun Kyung Cho(Hallym University, Korea) 
±³À°½Ã°£ 09-10 Room 3 13:19~13:26 Combination of statin and ezetimibe versus statin monotherapy on cardiovascular disease and type 2 diabetes incidence among adults with impaired fasting glucose: a propensity-matched study  You-Bin Lee(Sunkyunkwan University, Korea) 
±³À°½Ã°£ 09-10 Room 3 13:26~13:33 Higher non-high-density lipoprotein cholesterol was higher associated with CVD comparing higher LDL-C in nine years follow up  Sangmo Hong(Hanyang University, Korea) 
±³À°½Ã°£ 09-10 Room 3 13:33~13:40 Zmpste24 deficiency accelerates atherosclerosis in vascular smooth muscle cells  Soyoung Cho(Yonsei University, Korea) 
Åä·Ð 09-10 Room 3 13:40~14:05 Q&A  () 
±³À°½Ã°£ 09-10 Room 1+2+3 14:05~14:35 Optimal medical therapy to inhibit coronary plaque  Ken-ichi Hirata(Kobe University, Japan) 
È޽Ġ09-10  14:35~14:45 Break  () 
±³À°½Ã°£ 09-10 Room 1 14:45~15:08 Is remnant lipoprotein atherogenic?  Ki Hoon Han(University of Ulsan, Korea) 
±³À°½Ã°£ 09-10 Room 1 15:08~15:31 New therapeutics based on TG metabolism  Hye-Jin Yoo(Korea University, Korea) 
±³À°½Ã°£ 09-10 Room 1 15:31~15:54 Update on ANGPTL3 inhibition trials  Nathan Stitziel(University of Washington, USA) 
Åä·Ð 09-10 Room 1 15:54~16:20 Discussion  () 
±³À°½Ã°£ 09-10 Room 2 14:45~15:08 Latest target molecules in imaging early & late atherosclerosis  Jin-Won Kim(Korea University, Korea) 
±³À°½Ã°£ 09-10 Room 2 15:08~15:31 Molecular imaging in atherosclerosis  Jung-joon Min(Chonnam National University, Korea) 
±³À°½Ã°£ 09-10 Room 2 15:31~15:54 Update on invasive imaging of vulnerable plaque  So-Yeon Choi(Ajou University, Korea) 
Åä·Ð 09-10 Room 2 15:54~16:20 Discussion  () 
±³À°½Ã°£ 09-10 Room 3 14:45~15:08 Endothelial cell epigenetic factors regulating atherosclerosis  Hanjoong Jo(Emory University, USA) 
±³À°½Ã°£ 09-10 Room 3 15:08~15:31 Update on endothelial cell as target of anti-atherosclerosis treatment  Kyung-Sun Heo(Chungnam National University, Korea) 
±³À°½Ã°£ 09-10 Room 3 15:31~15:54 ROS regulation in vascular cells  Goo Taeg Oh(Ewha Womans University, Korea) 
Åä·Ð 09-10 Room 3 15:54~16:20 Discussion  () 
±³À°½Ã°£ 09-10 Room 4 14:45~15:03 Dietary cholesterol recommendation for cardiovascular risk  Sung Nim Han(Seoul National University, Korea) 
±³À°½Ã°£ 09-10 Room 4 15:03~15:21 Importance of dietary fatty acids in CV disease  Gwang-woong Go(Hanyang University, Korea) 
±³À°½Ã°£ 09-10 Room 4 15:21~15:39 Dietary fiber and dyslipidemia  Ji Yeon Kim(Seoul National University of Science and Technology, Korea) 
±³À°½Ã°£ 09-10 Room 4 15:39~15:57 Sodium dietary reference intakes based on CV disease  Min-Jeong Shin(Korea University, Korea) 
Åä·Ð 09-10 Room 4 15:57~16:20 Discussion  () 
È޽Ġ09-10  16:20~16:30 Break  () 
±³À°½Ã°£ 09-10 Room 1 16:30~16:53 What is trend & common points of latest lipid-lowering therapy guidelines?  Jong-Young Lee(Sungkyunkwan University, Korea) 
±³À°½Ã°£ 09-10 Room 1 16:53~17:16 Is current stratification of very-high risk appropriate?  Sung Hee Choi(Seoul National University, Korea) 
±³À°½Ã°£ 09-10 Room 1 17:16~17:39 Is current LDL-C target achievable?  Hidenori Arai(National Center for Geriatrics and Gerontology, Japan) 
Åä·Ð 09-10 Room 1 17:39~18:05 Discussion  () 
±³À°½Ã°£ 09-10 Room 2 16:30~16:53 Optimal treatment & LDL-C target for intermediate/low risk population  Samia Mora(Brigham and Women) 
±³À°½Ã°£ 09-10 Room 2 16:53~17:16 Timing & candidate of combination treatment  Sin-Gon Kim(Korea University, Korea) 
±³À°½Ã°£ 09-10 Room 2 17:16~17:39 Is it worth to adjust lipid-lowering therapy by ethinicity & how?  Mariko Harada-Shiba(National Cerebral and Cardiovascular Center Research Institute, Japan) 
Åä·Ð 09-10 Room 2 17:39~18:05 Discussion  () 
±³À°½Ã°£ 09-10 Room 3 16:30~16:53 Mechanism of vascular complications in obesity & metabolic syndrome  Soo Lim(Seoul National University, Korea) 
±³À°½Ã°£ 09-10 Room 3 16:53~17:16 Immunometabolic control in macrophages  Ichiro Manabe(Chiba University, Japan) 
±³À°½Ã°£ 09-10 Room 3 17:16~17:39 FABP as therapeutic target in ASCVD  Masato Furuhashi (Sapporo University, Japan) 
Åä·Ð 09-10 Room 3 17:39~18:05 Discussion  () 
±³À°½Ã°£ 09-10 Room 4 16:30~16:53 New insights mouse models of diabetes-accelerated atherosclerosis  Karin Bornfeldt(University of Washington, USA) 
±³À°½Ã°£ 09-10 Room 4 16:53~17:16 Fatty liver disease and gut ecosystem: microbiome and metabolome  Do Yup Lee(Seoul National University, Korea) 
±³À°½Ã°£ 09-10 Room 4 17:16~17:39 Proteomic studies in atherosclerotic cardiovascular disease  Kyung-Gon Kim(University of Ulsan, Korea) 
Åä·Ð 09-10 Room 4 17:39~18:05 Discussion  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Çѱ¹ÁöÁú¤ýµ¿¸Æ°æÈ­ÇÐȸ The 10th International Congress on Lipid & Atherosclerosis (ICoLA 2021) 1ÀÏÂ÷ : 2021-09-10""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ) Á¦15Â÷ ÇÑÀϳúÇ÷°ü¿Ü°úÇÐȸ (JKJC 2021) : 2021-09-10
´ÙÀ½±Û (¿Â¶óÀÎ) Á¦11ȸ ¼­¿ï¾Æ»êº´¿ø-±¹¸³º¸°Ç¿¬±¸¿ø ¾Ë·¹¸£±âÁúȯ ¿ªÇнÉÆ÷Áö¾ö : 2021-09-10
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20620 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼­¿ï¾Æ»êº´¿ø ´ç´¢º´ °³¿øÀÇ ¿¬¼ö°­Á : 2024-06-30 0 104 2024-04-30
20619 °æ³² »ï¼ºÃ¢¿øº´¿ø (¿Â¶óÀÎ)»ï¼ºÃ¢¿ø Ambulatory Pediatrics 2024 : 2024-06-29 0 88 2024-04-30
20618 °æºÏ Á¦8Â÷ ´ëÇѸðüžÆÀÇÇÐȸ °³¿øÀǸ¦ À§ÇÑ ¿¬¼ö°­ÁÂ(¿µ³²) : 2024-06-29 0 35 2024-04-30
20617 ¼­¿ï °Ç±¹´ëÇб³º´¿ø 2024 KUMC Precision Medicine Lung Cancer Conference : 2024-06-28 0 27 2024-04-30
20616 ¼­¿ï 2024 ´ëÇÑÇ÷¾×ÇÐȸ ÀûÇ÷±¸Áúȯ¿¬±¸ ½ÉÆ÷Áö¾ö : 2024-06-28 0 43 2024-04-30
20615 ¼­¿ï (¿Â¶óÀÎ)À̺ñÀÎÈÄ°ú Áö¿ªÀÇ»çÁý´ãȸ-°³¿ø°¡¿¡¼­ ÀÇ·ÚÇÑ µÎ°æºÎ¾Ï ȯÀÚÀÇ Ä¡·á ¹× °æ°ú : 2024-06-27 0 32 2024-04-30
20614 ¼­¿ï 2024³â ´ëÇÑÈäºÎ¿µ»óÀÇÇÐȸ ¿¬¼ö°­Á : 2024-06-23 0 28 2024-04-30
20613 ´ë±¸ ´ëÇѽºÆ÷Ã÷ÀÇÇÐȸ Sports Medicine Symposium 2024 in Daegu : 2024-06-23 0 66 2024-04-29
20612 ¼­¿ï 2024³â ´ëÇÑ°ñ´ë»çÇÐȸ Á¦12Â÷ Clinical Densitometry Course : 2024-06-23 0 46 2024-04-29
20611 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 1Â÷(2ÀÏÂ÷) : 2024-06-22 0 52 2024-04-29
20610 ¼­¿ï ¼­¿ï¾Æ»êº´¿ø (¿Â¶óÀÎ) 6¿ù 21ÀÏ ±Ý¿äÁý´ãȸ(ÀÌ°ü ÁúȯÀÇ Áø´Ü°ú Ä¡·á) : 2024-06-21 0 45 2024-04-29
20609 °æ±â ¾È»ê ¹× ½ÃÈ­Áö¿ª À̺ñÀÎÈÄ°ú Àǻ縦 À§ÇÑ Áý´ãȸ(¾È¸é¸¶ºñ) : 2024-06-21 0 35 2024-04-29
20608 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 1Â÷(1ÀÏÂ÷) : 2024-06-21 0 43 2024-04-29
20607 ¼­¿ï 2024 ´ëÇÑȯ°æõ½ÄÆóÁúȯÇÐȸ Ãá°èÇмú´ëȸ : 2024-06-21 0 48 2024-04-29
20606 ¼­¿ï (¿Â¶óÀÎ)À̺ñÀÎÈÄ°ú Áö¿ªÀÇ»çÁý´ãȸ-¿Ü·¡¿¡¼­ °£´ÜÇÏ°Ô ÇÒ ¼ö ÀÖ´Â À½¼ºÄ¡·á : 2024-06-20 0 31 2024-04-29
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷